Total Funding
11
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 11 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1905517
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
Bernard Courtieu: Chairman and Chief Executive OfficerPast Role: Ariba, Country Manager, France
Francois Liebaert: Vice President of R&D and Medical AffairsPast Role: Biosystems International, Chief Operating Officer and Vice President of Business Develpoment & Finance
About the Company
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms
to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

